000 01671 a2200493 4500
005 20250517194236.0
264 0 _c20180531
008 201805s 0 0 eng d
022 _a1432-1955
024 7 _a10.1007/s00436-017-5740-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPacheco, P A
245 0 0 _aInclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
_h[electronic resource]
260 _bParasitology research
_cMar 2018
300 _a705-712 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _a2-Hydroxypropyl-beta-cyclodextrin
_xchemistry
650 0 4 _aAlbendazole
_xchemistry
650 0 4 _aAnimals
650 0 4 _aAnthelmintics
_xchemistry
650 0 4 _aAntiparasitic Agents
_xchemistry
650 0 4 _aBiological Availability
650 0 4 _aCyclodextrins
_xchemistry
650 0 4 _aDrug Compounding
650 0 4 _aIntestinal Diseases, Parasitic
_xdrug therapy
650 0 4 _aMale
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aNematoda
650 0 4 _aNematode Infections
_xdrug therapy
650 0 4 _aPovidone
_xchemistry
650 0 4 _aSheep
650 0 4 _aSheep Diseases
_xdrug therapy
650 0 4 _aSolubility
650 0 4 _abeta-Cyclodextrins
_xchemistry
700 1 _aRodrigues, L N C
700 1 _aFerreira, J F S
700 1 _aGomes, A C P
700 1 _aVerĂ­ssimo, C J
700 1 _aLouvandini, H
700 1 _aCosta, R L D
700 1 _aKatiki, L M
773 0 _tParasitology research
_gvol. 117
_gno. 3
_gp. 705-712
856 4 0 _uhttps://doi.org/10.1007/s00436-017-5740-3
_zAvailable from publisher's website
999 _c27973496
_d27973496